Literature DB >> 18299662

Proteomic analysis of cervical cancer cells treated with adenovirus-mediated MDA-7.

Lili Wei1, Zhongtang Wang, Tao Cui, Faping Yi, Youquan Bu, Songtao Ding, Yongping Ma, Fangzhou Song.   

Abstract

Ad.mda-7 inhibited growth and decreased survival in a broad array of human tumor cells, without eliciting detrimental effects in normal cells. This study demonstrates that Ad.mda-7 can effectively impede the proliferation and induce apoptosis of human cervical carcinoma cells, but the underlying mechanisms inducing cell death at protein level are unknown. Using proteome analysis, an investigation aimed at a better understanding of the antiproliferative mechanisms by Ad.mda-7 was carried out in CaSki cervical cancer cells. A total of 43 differentially expressed proteins were visualized by 2-DE and silver stain., 29 proteins of which were identified via matrix-assisted laser desorption/ionization-time of flight mass spectrometry(MALDI-TOF-MS) analysis, 15 were upregulated (eg., Tumor suppressor p53, Apoptosis regulator BAX, Adenylate kinase isoenzyme 1(AK1), Growth arrest and DNA-damage-inducible protein GADD45 gamma (GADD45gamma)) and 14 were downregulated (e.g., Eukaryotic translation initiation factor 5A(eIF-5A), Protein DJ-1, Annexin V, Transcription elongation factor B polypeptide 2 (TCEB2), TRAF family member-associated NFkappaB activator (TRAF2),c-Myc-responsive protein Rcl (RCL)). Among the identified proteins, the protein and mRNA alterations of six proteins were further confirmed by Western blot and semi-quantitative RT-PCR. Together, at both the mRNA and protein levels, p53, BAX, AK1, GADD45gamma and BCCIP were upregulated, while eIF-5A was downregulated following Ad.mda-7 treatment. Our findings may offer new insights into the antiproliferative mechanisms by Ad.mda-7 and its mode of action in cervical carcinoma cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18299662     DOI: 10.4161/cbt.7.4.5478

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  5 in total

1.  Melanoma differentiation-associated gene-7/interleukin-24 as a potential prognostic biomarker and second primary malignancy indicator in head and neck squamous cell carcinoma patients.

Authors:  Lin Wang; Zhien Feng; Huanhuan Wu; Shuai Zhang; Yinfei Pu; Huan Bian; Yixiang Wang; Chuanbin Guo
Journal:  Tumour Biol       Date:  2014-08-05

Review 2.  Novel Insights into PARK7 (DJ-1), a Potential Anti-Cancer Therapeutic Target, and Implications for Cancer Progression.

Authors:  Wook Jin
Journal:  J Clin Med       Date:  2020-04-26       Impact factor: 4.241

3.  Inhibition of HIV-1 gene expression by Ciclopirox and Deferiprone, drugs that prevent hypusination of eukaryotic initiation factor 5A.

Authors:  Mainul Hoque; Hartmut M Hanauske-Abel; Paul Palumbo; Deepti Saxena; Darlene D'Alliessi Gandolfi; Myung Hee Park; Tsafi Pe'ery; Michael B Mathews
Journal:  Retrovirology       Date:  2009-10-13       Impact factor: 4.602

Review 4.  Recent insights into apoptosis and toxic autophagy: The roles of MDA-7/IL-24, a multidimensional anti-cancer therapeutic.

Authors:  Luni Emdad; Praveen Bhoopathi; Sarmistha Talukdar; Anjan K Pradhan; Devanand Sarkar; Xiang-Yang Wang; Swadesh K Das; Paul B Fisher
Journal:  Semin Cancer Biol       Date:  2019-07-26       Impact factor: 15.707

5.  Recombinant adenovirus vector-mediated human MDA-7 gene transfection suppresses hepatocellular carcinoma growth in a mouse xenograft model.

Authors:  Xinting Pan; Liqun Wu; Jingyu Cao; Weidong Guo; Zusen Wang; Bing Han; Weiyu Hu
Journal:  J Biomed Res       Date:  2012-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.